Sept 1 (Reuters) - MGC Pharmaceuticals Ltd (MXC) :
- FY NET LOSS FROM ORDINARY ACTIVITIES AFTER TAX ATTRIBUTABLE A$14 MILLION VERSUS LOSS OF A$19.4 MILLION
- FY REVENUE A$3 MILLION, UP 42.5%
News: MXC Mgc Pharmaceuticals Says FY Net Loss After Tax Attributable A$14 Mln
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
36.0¢ |
Change
-0.005(1.37%) |
Mkt cap ! $16.30M | |||
| Open | High | Low | Value | Volume |
| 36.5¢ | 36.5¢ | 36.0¢ | $5.514K | 15.30K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3904 | 36.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.5¢ | 200 | 1 |
View Market Depth
| Last trade - 12.53pm 28/05/2024 (20 minute delay) ? |
| RGT (ASX) Chart |